Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement-targeted therapies in kidney transplantation-insights from preclinical studies. | Front Immunol | 2022 | 36311730 | PubTator, text mining | PubMed |
| CAN'T INTUBATE, CAN'T OXYGENATE: A RARE CASE OF A DIFFICULT AIRWAY DUE TO NONHEREDITARY ANGIOEDEMA. | Acta Clin Croat | 2022 | 36304798 | PubTator, text mining | PubMed |
| Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells. | Nat Commun | 2022 | 36302757 | PubTator, text mining | PubMed |
| Adaptive immunity to SARS-CoV-2 infection: A systematic review. | Front Immunol | 2022 | 36300105 | PubTator, text mining | PubMed |
| Prevalence, Clinical Manifestations, Treatment, and Clinical Course of Chronic Urticaria in Elderly: A Systematic Review. | J Asthma Allergy | 2022 | 36299736 | PubTator, text mining | PubMed |
| High Throughput Genetic Characterisation of Caucasian Patients Affected by Multi-Drug Resistant Rheumatoid or Psoriatic Arthritis. | J Pers Med | 2022 | 36294757 | PubTator, text mining | PubMed |
| The Innate Immune Microenvironment in Metastatic Breast Cancer. | J Clin Med | 2022 | 36294305 | PubTator, text mining | PubMed |
| Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease. | Int J Mol Sci | 2022 | 36293475 | PubTator, text mining | PubMed |
| Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP. | Cells | 2022 | 36291127 | PubTator, text mining | PubMed |
| No prominent role for complement C1-esterase inhibitor in Marfan syndrome mice. | Vasc Biol | 2022 | 36279189 | PubTator, text mining | PubMed |
| Complement C1s as a diagnostic marker and therapeutic target: Progress and propective. | Front Immunol | 2022 | 36275687 | PubTator, text mining | PubMed |
| A performance evaluation study: Variant annotation tools - the enigma of clinical next generation sequencing (NGS) based genetic testing. | J Pathol Inform | 2022 | 36268089 | PubTator, text mining | PubMed |
| Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data. | Ann Transl Med | 2022 | 36267740 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing of retrieved human oocytes and eggs in clinical practice and for human ovarian cell atlasing. | Mol Reprod Dev | 2022 | 36264989 | PubTator, text mining | PubMed |
| Hereditary Angioedema Presenting as Isolated Jejunal Swelling. | J Community Hosp Intern Med Perspect | 2022 | 36262910 | PubTator, text mining | PubMed |
| Determining biomarkers for evaluation and diagnosis of hereditary angioedema. | Clin Transl Allergy | 2022 | 36254341 | PubTator, text mining | PubMed |
| Throat microbiota alterations in patients with hereditary angioedema. | World Allergy Organ J | 2022 | 36254183 | PubTator, text mining | PubMed |
| Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema. | J Med Chem | 2022 | 36251573 | PubTator, text mining | PubMed |
| Expression Analysis of Ligand-Receptor Pairs Identifies Cell-to-Cell Crosstalk between Macrophages and Tumor Cells in Lung Adenocarcinoma. | J Immunol Res | 2022 | 36249427 | PubTator, text mining | PubMed |
| The role of the astrocyte in subarachnoid hemorrhage and its therapeutic implications. | Front Immunol | 2022 | 36248855 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=41